merged_chronic-pain.txt
<other>First, I will analyze the article to find direct answers to the questions based on the provided text.</other>
<question_number>1</question_number>
<answer>N/A</answer>
<other>The article does not specify which pharmaceutical company's NaV 1.7 breakthrough drug was approved by the FDA in late 2023.</other>
<question_number>2</question_number>
<answer>N/A</answer>
<other>The article does not mention the number of hours per week the author spent doing nerve flossing exercises.</other>
<question_number>3</question_number>
<answer>N/A</answer>
<other>The article does not provide the specific percentage reduction in chronic pain symptoms from the Yale/VA carbamazepine study for osteoarthritis patients.</other>
<question_number>4</question_number>
<answer>N/A</answer>
<other>The author's blood tests did not reveal an autoimmune condition as the cause of her bilateral arm pain.</other>
<question_number>5</question_number>
<answer>N/A</answer>
<other>The article does not mention the name of the Washington University pain researcher who discovered the link between ketamine infusions and reduced nerve sensitization.</other>
<question_number>6</question_number>
<answer>N/A</answer>
<other>The article does not specify how many months it took for the author's colleague John to achieve complete pain relief after starting the experimental antibiotic treatment.</other>
<question_number>7</question_number>
<answer>N/A</answer>
<other>The article does not mention the average cost savings reported by patients who switched from traditional pain management to the UCSF integrated pain clinic approach.</other>
<question_number>8</question_number>
<answer>N/A</answer>
<other>The article does not specify which genetic marker Dr. Motzkin identified in the migraine patient's case that had been previously overlooked by other clinicians.</other>
<question_number>9</question_number>
<answer>N/A</answer>
<other>The article does not provide data on the percentage of chronic pain patients who showed improved outcomes when combining gabapentin with nerve flossing techniques according to the HEAL initiative.</other>
<question_number>10</question_number>
<answer>N/A</answer>
<other>The article does not specify how many dorsal root ganglion samples from chronic pain patients were required before Mwirigi's AI algorithm achieved 95% accuracy in cell identification.</other>
<question_number>11</question_number>
<answer>prostaglandin</answer>
<other>The molecule mentioned is prostaglandin, whose reduction due to a common anti-inflammatory drug’s action compromises the protective lining of the gut.</other>
<question_number>12</question_number>
<answer>NaV 1.7</answer>
<other>The sodium-channel subtype described as the “starting gate” for pain transmission and the focus of targeted drug design is NaV 1.7.</other>
<question_number>13</question_number>
<answer>dorsal root ganglion</answer>
<other>The cluster of cells responsible for relaying signals from the periphery to the central nervous system, likened to a bouquet of flowers, is the dorsal root ganglion.</other>
<question_number>14</answer>
<answer>20 years</answer>
<other>It had been two decades since a new non-opioid pain medication was introduced before recent advancements began emerging.</other>
<question_number>15</question_number>
<answer>hernia surgery</answer>
<answer>The type of surgery depicted as having a notably high likelihood of triggering long-lasting nerve pain is hernia surgery.</answer>
<question_number>16</question_number>
<answer>gabapentin</answer>
<answer>The anti-seizure medication that produced side effects such that patients confused color names, like “blue” for “green,” is gabapentin.</answer>
<question_number>17</question_number>
<answer>nerve flossing</answer>
<answer>The rehabilitative technique involving a distinctive gliding motion of the arms that provided some degree of nerve pain relief is nerve flossing.</answer>
<question_number>18</question_number>
<answer>clinical psychologist</answer>
<answer>The specialist who addresses both psychological and physical aspects of chronic pain and compares pain to an uninvited, persistent roommate is a clinical psychologist.</answer>
<question_number>19</question_number>
<answer>CB1</answer>
<answer>The cannabinoid receptor under investigation for its potential to offer pain relief without eliciting the psychoactive effects associated with cannabis is CB1.</answer>
<question_number>20</question_number>
<answer>new imaging technologies and computing abilities</answer>
<answer>The technological advance credited with enabling rapid mapping of receptor structures implicated in chronic pain is new imaging technologies and computing abilities.</answer>